Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$585M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$394M |
| 3 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$343M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$945M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$393M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$369M |
| 4 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$288M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Healthcare | 9.84% |
| 3 | Financials | 8.4% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Supernus Pharmaceuticals
SUPN
$2.77B
| $3.35M | ﹤0.01% |
133,319
-7,248
| -5% | -$156K |
|
|
TBIO
3002
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $3.35M | ﹤0.01% |
181,907
+49,890
| +38% | +$893K |
|
3003
Iovance Biotherapeutics
IOVA
$2.87B
| $3.35M | ﹤0.01% |
72,240
-44,567
| -38% | -$1.77M |
|
3004
WisdomTree US AI Enhanced Value Fund
AIVL
$436M
| $3.35M | ﹤0.01% |
39,950
-2,570
| -6% | -$207K |
|
|
DRNA
3005
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.35M | ﹤0.01% |
151,792
-5,681
| -4% | -$125K |
|
3006
iShares US Regional Banks ETF
IAT
$678M
| $3.34M | ﹤0.01% |
73,754
+18,636
| +34% | +$752K |
|
3007
Stride
LRN
$3.43B
| $3.34M | ﹤0.01% |
157,344
-89,158
| -36% | -$2.21M |
|
3008
First Trust Multi Cap Value AlphaDEX Fund
FAB
$176M
| $3.34M | ﹤0.01% |
57,266
+31,948
| +126% | +$1.71M |
|
3009
Invesco S&P International Developed Low Volatility ETF
IDLV
$348M
| $3.33M | ﹤0.01% |
111,222
+39,282
| +55% | +$1.14M |
|
3010
VanEck Long Muni ETF
MLN
$683M
| $3.33M | ﹤0.01% |
153,516
-3,640
| -2% | -$78.2K |
|
3011
Monro
MNRO
$398M
| $3.33M | ﹤0.01% |
62,470
+33,735
| +117% | +$1.54M |
|
3012
Fidelity MSCI Industrials Index ETF
FIDU
$2.39B
| $3.33M | ﹤0.01% |
70,806
+37,338
| +112% | +$1.65M |
|
|
PGRE
3013
DELISTED
Paramount Group
PGRE
| $3.33M | ﹤0.01% |
368,100
-51,269
| -12% | -$413K |
|
3014
Yext
YEXT
$574M
| $3.33M | ﹤0.01% |
211,640
+5,471
| +3% | +$93.6K |
|
|
REVG
3015
DELISTED
REV Group
REVG
| $3.32M | ﹤0.01% |
377,116
-12,904
| -3% | -$115K |
|
3016
Invesco Global Water ETF
PIO
$283M
| $3.32M | ﹤0.01% |
94,992
-4,274
| -4% | -$143K |
|
|
USCR
3017
DELISTED
U S Concrete, Inc.
USCR
| $3.32M | ﹤0.01% |
82,962
+640
| +0.8% | +$22.8K |
|
3018
iShares Russell Top 200 Value ETF
IWX
$4.03B
| $3.3M | ﹤0.01% |
57,007
+5,960
| +12% | +$326K |
|
|
ATRI
3019
DELISTED
Atrion Corp
ATRI
| $3.29M | ﹤0.01% |
5,127
-57
| -1% | -$35.4K |
|
|
AAMI
3020
Acadian Asset Management
AAMI
$3.19B
| $3.29M | ﹤0.01% |
170,764
+6,173
| +4% | +$104K |
|
3021
American Well
AMWL
$230M
| $3.28M | ﹤0.01% |
6,480
+5,515
| +572% | +$3.19M |
|
3022
Cytokinetics
CYTK
$10.4B
| $3.28M | ﹤0.01% |
157,902
+34,442
| +28% | +$629K |
|
|
QADA
3023
DELISTED
QAD Inc.
QADA
| $3.28M | ﹤0.01% |
51,913
+18,207
| +54% | +$935K |
|
3024
Middlesex Water
MSEX
$1.1B
| $3.28M | ﹤0.01% |
45,244
-1,101
| -2% | -$76.1K |
|
|
MRSN
3025
DELISTED
Mersana Therapeutics
MRSN
| $3.27M | ﹤0.01% |
4,922
-245
| -5% | -$136K |
|
Similar funds
Wells Fargo's Q4 2020 Portfolio in Review
As of Q4 2020, Wells Fargo held 7,511 positions worth $416B, up 15% from $362B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wells Fargo's Q4 2020 filing shows 430 new, 3,201 increased, 2,651 reduced and 319 closed positions. Its largest new stake was Foley Trasimene Acquisition Corp. II: 4,651,354 shares worth $70.2M. The largest sale was Tesla, an estimated $945M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Wells Fargo's largest Q4 2020 buy was Foley Trasimene Acquisition Corp. II: 4,651,354 shares worth $70.2M.
- Wells Fargo added most to iShares Russell 2000 ETF in Q4 2020, an estimated $585M increase.
- Wells Fargo's biggest Q4 2020 reduction was Tesla, cutting an estimated $945M.
- Wells Fargo fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $265M.
- Wells Fargo's ten largest holdings make up 15% of its $416B portfolio in Q4 2020.
- Wells Fargo opened 430 new positions and closed 319 in Q4 2020.
- Wells Fargo's portfolio value rose 15% quarter-over-quarter to $416B.
Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.